申请人:Gajewski Peter Robert
公开号:US20060293385A1
公开(公告)日:2006-12-28
The present invention relates to novel, non-secosteroidal, sulfonate and sulfonamide functional diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
本发明涉及一种新型的非
内酯类、
磺酸盐和磺酰胺类二芳基化合物,具有
维生素D受体(VDR)调节活性,比1α,25-二羟基
维生素D3更少引起高
钙血症。这些化合物可用于治疗骨病和牛皮癣。